The goal of this project is to understand immunological and genetic based differences in early and late bladder cancer tumorigenesis between genders. A mechanistic understanding of the gender differences in bladder cancer could translate to more precise therapeutic treatments of women to improve the gender disparity in bladder cancer and the survival of women with bladder cancer.
|Effective start/end date||8/1/20 → 7/31/21|
- Urology Care Foundation, Inc. (AGMT 6/1/20)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.